Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion

PACE - Pacing and Clinical Electrophysiology

Volumn 28, Issue SUPPL. 1, 2005, Pages

  Turco, Pietro ^a   De Simone, Antonio ^b   La Rocca, Vincenzo ^b   El Jamal, Bilal ^a   Nocerino, Pasquale ^b   Astarita, Costantino ^c   De Matteis, Carmine ^d   Messina, Vincenzo ^e   Greco, Luciano ^f   Rotunno, Raffaele ^g   Di Napoli, Tommaso ^h   Vitale, Dino Franco ⁱ   Stabile, Giuseppe ^b  

^a MARIA CECILIA HOSPITAL   (Italy)

^b Laboratorio di Elettrofisiologia   (Italy)

^c Ospedale Civile di Sorrento (NA)   (Italy)

^d Ospedale Civile di Arienzo (CE)   (Italy)

^e Ospedale Civile di Sarno (SA)   (Italy)

^f Ospedale Civile di Pagani (SA)   (Italy)

^g Ospedale Civile di Roccadaspide (SA)

^h Ospedale Civile di Polla (SA)

ⁱ Centro Medico di Telese (BN)   (Italy)

Author keywords

Ablation; Atrial flutter; Fibrillation

Indexed keywords

FLECAINIDE;

ADULT; AGED; CATHETER ABLATION; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INFERIOR CAVA VEIN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL HEART ATRIUM FIBRILLATION; PATIENT COMPLIANCE; TREATMENT OUTCOME;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; FLECAINIDE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; RECURRENCE; TIME FACTORS;

EID: 19944430782     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2005.00032.x     Document Type: Conference Paper

References (8)

1. Feld GK, Chen PS, Nicod P, et al. Possible atrial proarrhythmic effects of class IC antiarrhythmic drugs. Am J Cardiol 1990; 66:378-383.
2. Huang DT, Monaham KM, Zimetbaum P, et al. Hybrid pharmacological and ablative therapy: A novel and effective approach for the management of atrial fibrillation. J Cardiovasc Electrophysiol 1998; 9:462-469.
3. Nabar A, Rodriguez LM, Timmermans C, van den Dool A, Smeets JL, Wellens HJ. Effect of right atrial isthmus ablation on the occurrence of atrial fibrillation. Observations in four patient groups having type I atrial flutter with or without associated atrial fibrillation. Circulation 1999; 99:1441-1445.
4. Stabile G, De Simone A, Turco P, et al. Response to flecainide infusion predicts long-term success of hybrid pharmacologic and ablation therapy in patients with atrial fibrillation. J Am Coll Cardiol 2001; 37:1639-1644.
5. Jaïs P, Shah DC, Takahashi A, et al. Long-term follow-up after right atrial radiofrequency catheter treatment of paroxysmal atrial fibrillation. PACE 1998; 21(Pt. II):2533-2538.
6. Haissaguerre M, Shah DC, Jaïs P, et al. Electrophysiological breakthroughs from the left atrium to the pulmonary veins. Circulation 2000; 102:2463-2465.
7. Reithmann C, Dorwarth U, Dugas M, et al. Risk factors for recurrence of atrial fibrillation in patients undergoing hybrid therapy for antiarrhythmic drug-induced atrial flutter. Eur Heart J 2003; 24:1264-1272.
8. Stabile G, Bertaglia M, Senatore G, et al. Feasibility of pulmonary vein ostia radiofrequency ablation in patients with atrial fibrillation: A multicenter study (CACAF pilot study). PACE 2003; 26(Pt II):284-287.